research Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model
Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.
Moema, SP, Brazil
Niterói, RJ, Brazil
Mauá, SP, Brazil
Maurício de Nassau, PE, Brazil
Niterói, RJ, Brazil
Belo Horizonte, MG, Brazil